Shenzhen Neptunus Bioengineering Co

Shenzhen Neptunus Bioengineering Co Days Payable Outstanding

The Days Payable Outstanding (DPO) of Shenzhen Neptunus Bioengineering Co (000078.SZ) as of Oct 28, 2026 is 127.66. In the previous year, Days Payable Outstanding (DPO) was 120.88 — a change of 5.61% (higher).

Days Payable Outstanding

127.66

YoY

5.61%

Last updated:

Days Payable Outstanding (DPO) of Shenzhen Neptunus Bioengineering Co is 2025 127.66 . Days Payable Outstanding (DPO) of Shenzhen Neptunus Bioengineering Co was 2024 120.88 . It decreases by 5.61% higher compared to the previous year.

The Shenzhen Neptunus Bioengineering Co Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
12.29 CNY
Jan 1, 2019
122.00 CNY
Jan 1, 2020
110.66 CNY
Jan 1, 2021
100.12 CNY
Jan 1, 2022
107.81 CNY
Jan 1, 2023
110.65 CNY
Jan 1, 2024
120.88 CNY
Jan 1, 2025
127.66 CNY
The Shenzhen Neptunus Bioengineering Co Days Payable Outstanding history
YEARDays Payable OutstandingYoY
127.66+5.61%
120.88+9.25%
110.65+2.64%
107.81+7.68%
100.12-9.53%
110.66-9.29%
122.00+892.46%
12.29-92.34%
160.55-25.03%
214.16-12.24%
244.03+39.71%
174.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shenzhen Neptunus Bioengineering Co Stock analysis

What does Shenzhen Neptunus Bioengineering Co do? Shenzhen Neptunus Bioengineering Co., Ltd. generates revenue through its pharmaceutical products and healthcare offerings. The company produces anti-tumor products, cardiovascular drugs, marine drugs, respiratory drugs, anti-infective products, and other pharmaceuticals. It also sells healthcare products, health food, and medical instruments. The primary market for these products is the domestic market, with East China being the main regional focus. The company serves healthcare providers, hospitals, and consumers within China's pharmaceutical sector. Neptunus targets the Chinese domestic market, emphasizing East China as its core region. Its product portfolio spans multiple therapeutic areas including oncology, cardiology, respiratory care, and infection control. The company's distribution network focuses on reaching hospitals and healthcare facilities across China, particularly in the East China region. The firm's health food and medical instrument lines complement its pharmaceutical business, creating diversified revenue streams within the healthcare industry. The business model relies on selling established pharmaceutical products alongside healthcare and medical solutions. Anti-tumor products and cardiovascular drugs form key segments of its revenue, supported by marine drugs and respiratory medications. East China's dominance in sales reflects the company's strategic market focus. The company's full-time employee count of 9,874 supports its manufacturing and distribution operations across China's domestic market. Shenzhen Neptunus Bioengineering Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shenzhen Neptunus Bioengineering Co stock

Days Payable Outstanding (DPO) of Shenzhen Neptunus Bioengineering Co is 127.66 in 2025.

Days Payable Outstanding (DPO) of Shenzhen Neptunus Bioengineering Co changed from 120.88 to 127.66, representing a 5.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Shenzhen Neptunus Bioengineering Co since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Shenzhen Neptunus Bioengineering Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Shenzhen Neptunus Bioengineering Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Shenzhen Neptunus Bioengineering Co